Prostate cancer support and advocacy groups: Their role for patients and family members

Seminars in Urologic Oncology

Volumn 20, Issue 1, 2002, Pages 45-54

  Manne, Sharon L ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Family impact; Patient advocacy; Psychosocial issues; Support groups

Indexed keywords

ANXIETY NEUROSIS; CANCER DIAGNOSIS; CANCER PATIENT; COPING BEHAVIOR; DEPRESSION; EMOTION; FAMILY; GROUP PSYCHOLOGY; HUMAN; MALE; MEDICAL DECISION MAKING; PATIENT EDUCATION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; SPOUSE; SUPPORT GROUP;

EID: 0036171976     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.30398     Document Type: Review

References (53)

1. Psychosocial consequences of mastectomy: Levels of morbidity and associated factors
2. Determinants of the psycho-social outcome after operation for breast cancer: Results of a prospective comparative interview study following mastectomy and breast conservation
3. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial
4. Mastectomy or conservation for early breast cancer: Psychological morbidity
5. Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study
6. Psychological sequelae of cancer diagnosis: A meta-analytical review of 58 studies after 1980
7. Rapid screening for psychological distress in men with prostate carcinoma
8. Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners
9. Intrusion, avoidance, and psychological distress among individuals with cancer
10. Psychological distress and intrusive thoughts in cancer patients
11. Prevalence of posttraumatic stress disorder in women with breast cancer
12. Psychological responses to malignant melanoma an investigation of traumatic stress reactions to life-threatening illness
13. Quality of life of patients with prostate cancer and their spouses
14. Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years
15. Patient-reported impotence and incontinence after nerve sparing radical prostatectomy
16. Quality of life 12 months after radical prostatectomy
17. Quality of life assessment in patients with prostate cancer treated by radical prostatectomy, radiation therapy or a combination
18. Quality of life: Radical prostatectomy versus radiation therapy for prostate cancer
19. Quality-of-life outcomes in men treated for localized prostate cancer
20. Quality of life and treatment outcomes: Prostate carcinoma patients' persepctives after prostatectomy opr radiation therapy
21. Sexual function disorders after local radiotherapy for carcinoma of the prostate
22. Dimensions of quality of life expressed by men treated for metastatic prostate cancer
23. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids
24. Decreased sexual capacity after radiation therapy for prostate cancer impairs quality of life
25. Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a medicare survey
26. Changes in quality of life following treatment for early prostate cancer
27. Prostate cancer
28. Dilemmas in managing prostatic carcinoma. II. Metastatic disease
29. The prevalence and severity of pain in cancer
30. Comparison of prostate cancer patients with and without pain
31. Education and peer discussion group interventions and adjustment to breast cancer
32. Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer
33. Group support for patients with metastatic cancer
34. An alternative group approach. Using multidisciplinary expertise to support patients with prostate cancer and their families
35. The effectiveness of a professionally led support group for men with prostate cancer
36. Interviews with men with prostate cancer about their self-help experience
37. Effects of a psychosocial intervention on survival among patients with stage I breast and prostate cancer: A matched case-control study